Sanofi and CD&R Sign Share Purchase Agreement for Opella

Following completion of the required social and corporate procedures, Sanofi and CD&R have signed the share purchase agreement for the sale of a 50% controlling stake in its consumer health business Opella to US private equity firm Clayton Dubilier & Rice (CD&R).

Bpifrance is expected to participate as a minority shareholder with a stake of about 2% stake in Opella, with Sanofi remaining a significant shareholder.

The terms of the transaction remain unchanged from those previously announced and closing is expected in the second quarter of 2025 at the earliest.

This transaction remains subject to obtaining customary regulatory approvals from the competent authorities.

© AVAVA/Shutterstock
© AVAVA/Shutterstock

Company

Logo:

Sanofi S.A.

46-48 Avenue de la Grande Armée
Paris
France

Company contact







Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.